[Cancer and deep vein thrombosis].
Cancer patients with thrombosis and haemorrhagy are a particular problem. They have an increased risk of deep vein thrombosis and pulmonary embolism, and they're more prone to bleeding from anticoagulant therapy. So it really is a dilemma. Clinical research has shown that prevention and initial therapy can consist of subcutaneous low-molecular-weight heparin for an initial period, followed by long-term anticoagulant therapy.
Malý
J
J
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D006487:Hemostasis; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D010257:Paraneoplastic Syndromes / Q000150:complications*; D013923:Thromboembolism / Q000150:complications; D020246:Venous Thrombosis / Q000150:complications* / Q000517:prevention & control
D000925:Anticoagulants